Mateon Therapeutics, a California-based biopharmaceutical company, has completed its acquisition of PointR Data, a technology company focused on AI and other advanced technologies.

HeartVista, a Los Altos, California-based healthcare technology company, has received FDA clearance for its AI-powered One Click cardiac MRI solution.

Two healthcare companies focused on AI-powered technologies—Densitas and MaxQ AI—have announced that they will have FDA-approved solutions available on the Nuance AI Marketplace.

Microsoft and Humana have announced a new seven-year strategic partnership that will aim to improve the efficiency and effectiveness of the healthcare solutions available to Humana’s members.

Intelerad Medical Systems and Zebra Medical Vision have announced a new partnership involving Intelerad’s Odyssey workflow management solution.

The use of AI continues to rise throughout the United States, according to a new industry report published by RELX. The report included feedback from more than 1,000 senior-level executives representing seven industries: healthcare, science/medical, government, insurance, legal, banking and agriculture.

MaxQ AI has announced that its AI-based intracranial hemorrhage (ICH) and stroke software will soon be integrated into Philips CT scanners.

VIDA Diagnostics, a Coralville, Iowa-based medical imaging company, has announced a new distribution deal with TeraRecon.

As more businesses begin to implement state-of-the-art technologies, one industry expert is predicting AI will boost the global economy by $14 trillion by the year 2035.

The continued evolution of AI will lead to more job opportunities in the healthcare industry, according to new survey of high-ranking executives. Investments in AI and the implementation of AI-focused strategies are both also on the rise.  

Some 46% of Americans are open to the idea of their physicians using AI to help make diagnoses.

Physicians who reject an AI-based recommendation of established care guidelines in order to provide more personalized medicine are at heightened risk of being sued for malpractice should the patient be harmed.